Pith. sign in

REVIEW 4 major objections 6 minor 35 references

Could short-lasting non-specific immunity explain seasonal spacing of epidemic diseases?

T0 review · 4 major / 6 minor · reviewed 2026-08-14 · deepseek-v4-flash

Pith's one-line read Short-lived non-specific immunity can make epidemics alternate without any seasonal forcing.

desk verdict The core dynamical claim – that short-lived non-specific immunity can make SIRS systems oscillate and alternate epidemics – is real and worth referee time, but the PIV/seasonality part is a parameter-tuned illustration, not a test. read the letter →

arxiv 1908.00925 v1 pith:G45RJ6AB submitted 2019-08-02 q-bio.PE nlin.AOphysics.bio-phphysics.soc-ph

classification q-bio.PEnlin.AOphysics.bio-phphysics.soc-ph MSC 92D30
keywords seasonalepidemicsnon-specificimmunitydiseaseinteractionSIRSmodelepidemiclimitcyclesparainfluenzamathematicalepidemiology
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

This paper asks whether a single, short-lasting burst of non-specific immunity—lasting only a few weeks—can explain why different respiratory viruses peak in different seasons. It claims that when several diseases share one host population and each infection-like contact briefly protects against all of them, the diseases spontaneously take turns: recurrent alternating epidemics occur even with no seasonal forcing. With one annual driver added, the same mechanism reproduces sequentially spaced seasonal peaks, including the observed biennial PIV-1 and annual PIV-3 pattern. If true, complex seasonal ordering of epidemics need not be blamed on a different environmental trigger for each virus.

What carries the argument

The key machinery is an extended SIRS model with a host state for general immunity, G: a host is either susceptible, infectious, or specifically immune for each disease, and additionally either protected or unprotected by a non-specific immunity that lasts on average TG time units. The non-specific immunity is switched on by any contact with any disease—even when specific immunity prevents infection—and blocks infection by all diseases while active. This state, inserted between exposure and infection, is what turns the model's endemic equilibrium into a Hopf bifurcation and sustains periodic epidemics; the duration TG acts as the interaction-strength control parameter.

What would settle it

A direct test would compare two groups of animals exposed to pathogen B either after a contact that did not produce a full infection with pathogen A or after a full A infection; if contact alone does not shorten or block B infection, the model's strongest-interaction regime is not realized. A second check is measuring the duration TG required for alternating epidemics in a two-pathogen experiment and comparing it with the model's predicted bifurcation threshold.

Watch

Extended reading notes

Core claim

The paper's central discovery is that adding a short non-specific immune state to the classical SIRS model destabilizes the steady endemic equilibrium and produces stable epidemic limit cycles. In the two-disease case, disease A's outbreak temporarily shields the host population from disease B; while B is suppressed, the pool of hosts susceptible to B grows, so when the non-specific protection fades B erupts in a large epidemic, and the roles reverse. This gives alternating recurrent epidemics for realistic parameters (long specific immunity, R0 around 2.5, non-specific immunity of a few weeks). Under a single seasonal modulation of transmissibility, the interaction spreads the epidemic peaks of otherwise identical diseases across the year, and a tuned two-disease version matches several qualitative features of US parainfluenza PIV-1/PIV-3 time series, including deeper PIV-3 valleys and delayed PIV-3 peaks in PIV-1 years.

Load-bearing premise

The load-bearing assumption is that every contact with a pathogen—even one that cannot cause infection because the host already has specific immunity—activates the short non-specific protection; if activation requires a productive infection, the disease interaction is weaker and the alternating-epidemic regime may shrink or disappear.

Editorial extensions

If this is right

  • In a population with two similar respiratory pathogens, the model predicts spontaneous anti-phase epidemic cycles for a wide range of realistic transmission and immunity parameters.
  • A single seasonal driver is sufficient to generate sequentially spaced epidemics of diseases that have identical dynamics; distinct environmental drivers for each virus are not required.
  • The model reproduces the distinctive PIV-1/PIV-3 pattern: annual PIV-3 peaks, biennial PIV-1 peaks, deeper PIV-3 valleys, and delayed PIV-3 peaks in PIV-1 years.
  • With more than a few diseases, sustained alternating epidemics require narrow epidemic spikes, so larger transmissibility and longer specific immunity increase the number of diseases that can be spaced in time.
  • Without non-specific immunity, the same two-disease system with the same seasonal driver would produce annual outbreaks of both diseases, so the interaction is what explains the spacing.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • If the paper is right, observed seasonal 'niches' of respiratory viruses may be partly an emergent property of pathogen competition, and vaccination campaigns against one respiratory virus could temporarily suppress others via the same non-specific window.
  • The mechanism implies that short cross-protective windows should be detectable in routine surveillance as negative correlations between unrelated respiratory virus activities at lags of weeks to months.
  • An extension worth testing is whether adding a second, longer non-specific immune component can reproduce multi-year patterns such as RSV's biennial cycle and influenza's subtype alternations.
Share X Bluesky LinkedIn Reddit HN

Signed reviews

No signed human review yet.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

4 major / 6 minor

Summary. The manuscript proposes an extension of the classical SIRS model to multiple diseases that interact through a short-lasting, non-specific immunity (G) state. The authors show, via direct simulation and local stability analysis, that sufficiently long non-specific immunity (TG) can produce recurrent alternating epidemic cycles even without seasonal forcing, and that with a single seasonal driver the model can produce sequential epidemic patterns with different phases. They apply the model to US parainfluenza data (PIV-1 and PIV-3), claiming to reproduce several qualitative features including biennial PIV-1 peaks, deeper PIV-3 valleys in PIV-1 years, delayed PIV-3 peaks, and asymmetric PIV-1 epidemic shape. The central claim is that a few-weeks-long non-specific immune response is sufficient to explain seasonal spacing of unrelated respiratory viruses.

Significance. If the central claim is correct, the paper offers a parsimonious mechanism for seasonally spaced epidemics without invoking a separate environmental driver for each virus, and it provides a concrete, testable model of disease interference via short-lived innate or club-cell-mediated immunity. The paper's strength is that the alternating-epidemic phenomenon is derived rather than fitted: the Hopf-bifurcation analysis and deterministic/stochastic simulations agree, and the model is simple enough to be reproduced from the text. The PIV-1/PIV-3 comparison is a genuine attempt to confront the model with data. However, the significance is qualified by the model's strong activation assumption and by the fact that the PIV reproduction involves substantial parameter tuning without uncertainty quantification.

major comments (4)
  1. [Sec. II, Multiple diseases] The model assumes that non-specific immunity is activated on every contact with any disease, even when host-specific immunity prevents infection, as stated in Sec. II: 'The non-specific immunity is activated (Goff→Gon) every time a host comes into contact with any of the diseases, also if infection is prevented by specific immunity.' This maximizes inter-disease coupling and is the key nonlinearity that generates the Hopf bifurcation behind alternating epidemics (Sec. III.1, Figs. 2–3). The only robustness check reported, 'twice as long, but not fully protective (50%)' with data not shown, varies the duration and strength of G but not the triggering condition. If activation requires a productive infection (S→I), hosts in R for one disease would not enter G upon contact with that disease, reducing the protected pool and weakening the postponement mechanism that builds large susceptible pools. The paper should test this alternative triggering rule and show whether the alternating-epidemic regime persists for biologically plausible parameters.
  2. [Sec. II, Model and Methods; Sec. III.1] The deterministic rate equations are never written out. The text describes the model verbally and gives parameter values, and Sec. III.1 states that a linear stability analysis was performed on a grid, but the equations for the multi-disease SIRS model with the G state are not displayed. Without the explicit equations, the Hopf-bifurcation calculation cannot be independently checked, and the reader cannot verify how the external reservoir, the seasonal forcing R0(t), and the symmetry-breaking initial conditions enter the deterministic system. Please provide the full set of ordinary differential equations, including the G-transition terms, and specify the numerical method used for the bifurcation analysis.
  3. [Sec. III.5, Fig. 6] The PIV-1/PIV-3 'reproduction' is a parameter-tuned qualitative match rather than an estimated fit. The parameters TR,PIV-1, TR,PIV-3, TG, the seasonal amplitude c, the phase offset (peak aligned to March 1), and the external reservoir size are all chosen to reproduce the observed pattern, yet no uncertainty quantification, sensitivity analysis, or systematic parameter search is provided. In particular, the statement that the same model 'without non-specific immunity' converges to annual epidemics for both diseases is a useful control, but it does not establish that the tuned parameter set is biologically plausible or that the fit is unique. To support the claim that the model 'reproduces multiple features,' the authors should show how sensitive the four listed features (biennial PIV-1, deep PIV-3 valleys, delayed PIV-3 peaks, asymmetric PIV-1 shape) are to variations in each tuned parameter, and ideally compare the model output to data quantitatively (e.g., peak timing and valley depth).
  4. [Sec. II, Simulation details; Fig. 2c] The stability diagram in Fig. 2c and the matching statement in Sec. III.1 ('The amplitudes measured in deterministic simulations match well with the calculated bifurcation lines') are not fully documented. The plotted quantity is log10(Imax/Imin), which is a spikiness measure rather than a true amplitude, and the white dashed line is described only as a bifurcation line. It would be helpful to show explicitly how the bifurcation line was computed from the linearized equations and to report the agreement between the predicted oscillation period/amplitude and the simulated values. Without this, the reader cannot separate the contribution of the Hopf calculation from the simulation-based color map.
minor comments (6)
  1. [Abstract] The abstract contains a typo: 'cloub cell' should be 'club cell'.
  2. [Fig. 6 caption] The caption states 'TR,P IV 1 = 170TI and TR,P IV 1 = 120TI'; the second should presumably be TR,P IV 3 = 120TI. Please correct the label.
  3. [Fig. 3 caption] The caption uses '∆T0' where the text and equations define ∆TR; this is inconsistent and should be fixed.
  4. [Sec. II, Model parameters] The notation 'R0(t) = 2 + c·sin(2πt/τ)' is clear, but the relationship between the base R0=2.5 used in the no-seasonality cases and the seasonal mean of 2 in Sec. III.4 and III.5 should be stated explicitly to avoid confusion.
  5. [Sec. IV, Discussion] The statement 'This seems to indicate, that the observed effect would not occur just because of behavioural changes caused by the sickness, such as staying home from work' is an interesting inference, but the model does not explicitly include behavior; please rephrase to avoid overclaiming.
  6. [Data, code and materials] The paper says the model is 'completely reproducible from the description in the main text,' but no code or data repository is given. Since the simulations and the extracted PIV time series are nontrivial, providing code and the digitized data would materially aid reproducibility.

Circularity Check

0 steps flagged · score 0.0 of 10

No significant circularity: the recurrent-epidemic result is an emergent model property, and the PIV comparison is explicitly a parameter-tuned reproduction rather than an out-of-sample prediction.

full rationale

The paper's central derivation chain is self-contained. The model is a multi-disease SIRS extension with a non-specific immunity compartment G; recurrent alternating epidemics are obtained from agent-based and deterministic simulations and from a linear-stability/Hopf-bifurcation analysis (Sec. III.1, Figs. 2-3), not by inserting the target pattern as an assumption. The seasonal-pattern results (Sec. III.4, Fig. 5) are generated by varying TG under fixed seasonal forcing and are not fit to specific empirical time series. The only data comparison, the PIV-1/PIV-3 application (Sec. III.5, Fig. 6), is described as reproducing observed features, not as predicting them from fixed constants; the caption states the chosen parameters (TG=4TI, TR,PIV1=170TI, TR,PIV3=120TI, R0(t)=2+0.2 sin, phase aligned to March 1, external reservoir 1/200,000). This is a post-hoc sufficiency demonstration with tuned parameters, which limits the strength of the empirical evidence but does not make the claim circular in the defined sense. There are no load-bearing self-citations: the paper cites prior related work by Rohani et al. [11,14,16] and explicitly acknowledges that similar interference phenomena were observed in those models, while the present contribution adds the SIRS/waning-immunity framework and bifurcation analysis. No uniqueness theorem is imported from the authors' own prior work, and no fitted parameter is renamed as a prediction. The core theoretical claim therefore stands as an emergent derivation from the model assumptions rather than a reduction to its inputs.

Assumptions & free parameters 7 free parameters · 7 assumptions · 0 invented entities

The model's central mechanism rests on standard SIRS assumptions plus two additions: immediate activation of non-specific immunity on any disease contact, and short-lived 100% protection during the active window. The PIV reproduction additionally relies on tuned parameters (TR values, TG, seasonal amplitude and phase, external reservoir concentration) that are set to match the same data they are compared against, which is the main circular element.

free parameters (7)
  • Basic reproduction number R0 (base) = 2.5 (nonseasonal case studies)
    Selected as representative for respiratory viruses; in Fig. 2c R0 is scanned from 1 to 7, showing the oscillatory regime for most reasonable values.
  • R0 seasonal amplitude c = 0.1 or 0.2 in different figures
    Chosen for the seasonal case studies; the PIV simulation uses c = 0.2 to match the observed pattern.
  • Specific immunity duration TR = 100 TI (generic); 170 TI for PIV-1 and 120 TI for PIV-3
    The paper states 'Unless stated otherwise TR = 100'. The PIV-specific values are tuned to reproduce the biennial/annual pattern.
  • Non-specific immunity duration TG = 4 TI in PIV case; scanned 0.1-15 TI elsewhere
    Central interaction-strength parameter; the recurrent-epidemic regime requires TG above a threshold around a few TI.
  • Seasonal phase offset = Annual R0 maxima aligned to March 1
    Aligned to the PIV surveillance data so the simulated peaks match the observed seasonal timing.
  • External reservoir concentration = 1/200,000 of population (seasonal simulations); 1/500,000 otherwise
    Introduced to shorten the transient period; not derived from data and affects the phase-locking.
  • Initial condition symmetry breaking = 1/1000 infectious with disease 1, 2/1000 with disease 2
    Chosen to break symmetry between identical diseases in deterministic simulations; may influence which attractor is selected.
assumptions (7)
  • domain assumption Homogeneous, fully mixed host population with mass-action transmission (standard SIRS).
    Invoked in Sec. II: 'Our model is based on the traditional SIRS-model with a homogeneous, fully mixed host population.' No age, spatial, or contact structure.
  • ad hoc to paper Non-specific immunity is activated on every contact with any disease, even when infection is blocked by specific immunity.
    Sec. II: 'The non-specific immunity is activated (Goff to Gon) every time a host comes into contact with any of the diseases, also if infection is prevented by specific immunity.' This maximizes interaction and is not empirically established.
  • ad hoc to paper While active, non-specific immunity is 100% effective at blocking infection.
    Sec. II reports similar results for 50% effectiveness (data not shown), so the precise efficacy is not load-bearing, but the assumption is still idealized.
  • domain assumption Specific immunity wanes with a mean duration TR, allowing reinfection (SIRS).
    Appropriate for PIV and RSV; for influenza, the paper abstracts antigenic drift as waning immunity (Sec. I).
  • domain assumption An external reservoir of constantly infectious hosts prevents stochastic extinction.
    Sec. II 'Simulation details'; the reservoir represents importation and avoids extinction, which is common but affects dynamics and transient.
  • domain assumption Seasonal forcing is a single sinusoidal modulation of R0 with period one year.
    Sec. III.4, R0(t) = 2 + 0.1*sin(2*pi*t/tau); used throughout to represent the environmental driver.
  • domain assumption The extracted PIV-1/PIV-3 surveillance data from Fry et al. is sufficiently accurate for qualitative comparison.
    The authors estimate extraction uncertainty of +-10 days and +-0.2% from a low-quality figure; they do not propagate this into the comparison.

how reviews work

0 comments
Cite this review

Pith. "Pith review of Could short-lasting non-specific immunity explain seasonal spacing of epidemic diseases?." pith.science (2026). https://pith.science/paper/G45RJ6AB

@misc{pith2026190800925,
  author       = {Pith},
  title        = {Pith review of: Could short-lasting non-specific immunity explain seasonal spacing of epidemic diseases?},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/G45RJ6AB}},
  note         = {Machine review of arXiv:1908.00925}
}
read the original abstract

Common respiratory viruses cause seasonal epidemics in sequential patterns. The underlying mechanisms for this pattern have been debated for some time. For influenza, contenders include temperature, humidity, and vitamin D levels. While such seasonal drivers may be sufficient to explain midwinter peaking it is unclear if other respiratory viruses peaking in spring, summer, or fall have individual environmental drivers. Here we present a dynamic model of interacting diseases, in an effort to explain observed seasonal patterns without requiring multiple seasonal drivers. Our model extends the classical SIRS-model to include multiple diseases that interact via a short-lasting, non-specific immunity component. This temporal protection is triggered by exposure to any epidemic disease and lasts only a couple of weeks. We show that the inhibiting disease-interaction allows recurrent epidemic behaviour without any seasonal driving. In the presence of a single seasonal driver our model parsimoniously predicts epidemic patterns such as sequentially occurring epidemic diseases. We also present a two-disease simulation reproducing multiple features observed in time series of parainfluenza strains PIV-3 and biennial PIV-1 epidemic patterns. Complex epidemic patterns of seasonal diseases may be explained by non-specific innate or cloub cell (T-cell) mediated immune responses that result in interaction between unrelated respiratory epidemic diseases.

Figures

Figures reproduced from arXiv: 1908.00925 by the authors.

Figure 1
Figure 1. Model from the perspective of individual hosts. [PITH_FULL_IMAGE:figures/full_fig_p002_1.png] view at source ↗
Figure 2
Figure 2. Dynamics with two diseases with mean specific [PITH_FULL_IMAGE:figures/full_fig_p004_2.png] view at source ↗
Figure 4
Figure 4. More than 2 diseases in deterministic simulations [PITH_FULL_IMAGE:figures/full_fig_p005_4.png] view at source ↗
Figures from the paper (1 more)
Figure 6
Figure 6. Figure 6: Upper panel: Seasonal variant of the deterministic model with two diseases, resembling PIV-1 and PIV-3. The [PITH_FULL_IMAGE:figures/full_fig_p006_6.png]

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

35 extracted references · 35 canonical work pages

  1. [1]

    A new concept of the epidemic process of influenza a virus

    RE Hope-Simpson and DB Golubev. A new concept of the epidemic process of influenza a virus. Epidemiology and infection, 99(01):5–54, 1987

  2. [2]

    Melatonin me- diates seasonal adjustments in immune function

    Randy J Nelson and Deborah L Drazen. Melatonin me- diates seasonal adjustments in immune function. Repro- duction Nutrition Development , 39(3):383–398, 1999

  3. [3]

    Update: Influenza activity-united states

    S Smith, L Blanton, K Kniss, D Mustaquim, C Steffens, C Reed, A Bramley, B Flannery, AM Fry, LA Grohskopf, et al. Update: Influenza activity-united states. MMWR. Morbidity and mortality weekly report , 64(48):1342, 2015

  4. [4]

    Seasonal trends of human parainfluenza viral infections: United states, 1990–2004

    Alicia M Fry, Aaron T Curns, Kathryn Harbour, Lori Hutwagner, Robert C Holman, and Larry J Anderson. Seasonal trends of human parainfluenza viral infections: United states, 1990–2004. Clinical Infectious Diseases , 43(8):1016–1022, 2006

  5. [5]

    Epidemiological features of parain- fluenza virus infections: laboratory surveillance in eng- land and wales, 1975–1997

    Henri Laurichesse, Daniel Dedman, John M Watson, and Maria C Zambon. Epidemiological features of parain- fluenza virus infections: laboratory surveillance in eng- land and wales, 1975–1997. European journal of epidemi- ology, 15(5):475–484, 1999

  6. [6]

    R0,TI andTR can be disease specific parameters

    See individual figure for specific values. R0,TI andTR can be disease specific parameters. Unless stated otherwise, they are chosen to be identical for all diseases. The mean duration of specific immunity is rather short in most simulations (few years). This reflects the fact that immunity is often incomplete in viruses such as PIV[30] and RSV[31], which allow...

  7. [7]

    Human parain- fluenza virus-associated hospitalizations among children less than five years of age in the united states

    Molly E Counihan, David K Shay, Robert C Holman, Sara A Lowther, and Larry J Anderson. Human parain- fluenza virus-associated hospitalizations among children less than five years of age in the united states. The Pe- diatric infectious disease journal , 20(7):646–653, 2001

  8. [8]

    Seasonal variation in peripheral blood leukocyte subsets and in serum interleukin-6, and solu- ble interleukin-2 and-6 receptor concentrations in normal volunteers

    M Maes, W Stevens, S Scharpe, E Bosmans, F De Meyer, P D’Hondt, D Peeters, P Thompson, P Cosyns, L De Clerck, et al. Seasonal variation in peripheral blood leukocyte subsets and in serum interleukin-6, and solu- ble interleukin-2 and-6 receptor concentrations in normal volunteers. Experientia, 50(9):821–829, 1994

Show all 35 references
  1. [9]

    Seasonal dif- ferences in the rhythmicity of human male and female lymphocyte blastogenic responses

    FN Boctor, RA Charmy, and EL Cooper. Seasonal dif- ferences in the rhythmicity of human male and female lymphocyte blastogenic responses. Immunological inves- tigations, 18(6):775–784, 1989

  2. [10]

    Seasonal variation in host susceptibil- ity and cycles of certain infectious diseases

    Scott F Dowell. Seasonal variation in host susceptibil- ity and cycles of certain infectious diseases. Emerging infectious diseases, 7(3):369, 2001

  3. [11]

    Epidemic influenza and vitamin d

    JJ Cannell, R Vieth, JC Umhau, MF Holick, WB Grant, S Madronich, CF Garland, and E Giovannucci. Epidemic influenza and vitamin d. Epidemiology and infection, 134 (06):1129–1140, 2006

  4. [12]

    Population dynamic interference among childhood diseases

    Pejman Rohani, David J Earn, B Finkenst¨ adt, and Bryan T Grenfell. Population dynamic interference among childhood diseases. Proceedings of the Royal So- ciety of London B: Biological Sciences , 265(1410):2033– 2041, 1998

  5. [13]

    Cross- immunity between strains explains the dynamical pattern of paramyxoviruses

    Samit Bhattacharyya, Per H Gesteland, Kent Korgen- ski, Ottar N Bjørnstad, and Frederick R Adler. Cross- immunity between strains explains the dynamical pattern of paramyxoviruses. Proceedings of the National Academy of Sciences, 112(43):13396–13400, 2015

  6. [14]

    The effect of cross- immunity and seasonal forcing in a multi-strain epidemic model

    Masashi Kamo and Akira Sasaki. The effect of cross- immunity and seasonal forcing in a multi-strain epidemic model. Physica D: Nonlinear Phenomena , 165(3):228– 241, 2002

  7. [15]

    The dynamical im- plications of disease interference: correlations and co- existence

    Yunxin Huang and Pejman Rohani. The dynamical im- plications of disease interference: correlations and co- existence. Theoretical population biology, 68(3):205–215, 2005

  8. [16]

    Tracking the dynamics of pathogen interactions: model- ing ecological and immune-mediated processes in a two- pathogen single-host system

    Daniel A Vasco, Helen J Wearing, and Pejman Rohani. Tracking the dynamics of pathogen interactions: model- ing ecological and immune-mediated processes in a two- pathogen single-host system. Journal of theoretical biol- ogy, 245(1):9–25, 2007. 8

  9. [17]

    Ecological interference between fatal diseases

    P Rohani, CJ Green, NB Mantilla-Beniers, and BT Gren- fell. Ecological interference between fatal diseases. Na- ture, 422(6934):885–888, 2003

  10. [18]

    Dynamics of interacting diseases

    Joaqu´ ın Sanz, Cheng-Yi Xia, Sandro Meloni, and Yamir Moreno. Dynamics of interacting diseases. Physical Re- view X , 4(4):041005, 2014

  11. [19]

    Graham, Fabrice Carrat, Oliver Ratmann, and Bernard Cazelles

    Anton Camacho, S´ ebastien Ballesteros, Andrea L. Graham, Fabrice Carrat, Oliver Ratmann, and Bernard Cazelles. Explaining rapid reinfections in multiple-wave influenza outbreaks: Tristan da cunha 1971 epidemic as a case study. Proceedings of the Royal Society of London B: Biol...

  12. [20]

    Mod- eling within-host dynamics of influenza virus infection including immune responses

    Kasia A Pawelek, Giao T Huynh, Michelle Quinlivan, Ann Cullinane, Libin Rong, and Alan S Perelson. Mod- eling within-host dynamics of influenza virus infection including immune responses. PLoS Comput Biol , 8(6): e1002588, 2012

  13. [21]

    Dynamics of influenza virus infection and pathology

    Roberto A Saenz, Michelle Quinlivan, Debra Elton, Shona MacRae, Anthony S Blunden, Jennifer A Mum- ford, Janet M Daly, Paul Digard, Ann Cullinane, Bryan T Grenfell, et al. Dynamics of influenza virus infection and pathology. Journal of virology , 84(8):3974– 3983, 2010

  14. [22]

    Innate immunity and the inter-exposure interval de- termine the dynamics of secondary influenza virus infec- tion and explain observed viral hierarchies

    Pengxing Cao, Ada WC Yan, Jane M Heffernan, Stephen Petrie, Robert G Moss, Louise A Carolan, Teagan A Guarnaccia, Anne Kelso, Ian G Barr, Jodie McVernon, et al. Innate immunity and the inter-exposure interval de- termine the dynamics of secondary influenza virus infec- tion and ...

  15. [23]

    A model of non- specific immunity

    Rustom Antia and Jacob C Koella. A model of non- specific immunity. Journal of theoretical biology , 168(2): 141–150, 1994

  16. [24]

    The unspecific side of acquired immu- nity against infectious disease: Causes and consequences

    Eric Muraille. The unspecific side of acquired immu- nity against infectious disease: Causes and consequences. Frontiers in Microbiology, 6, 2015

  17. [25]

    Ecological and immunological determinants of influenza evolution

    Neil M Ferguson, Alison P Galvani, and Robin M Bush. Ecological and immunological determinants of influenza evolution. Nature, 422(6930):428–433, 2003

  18. [26]

    Training innate immunity: the changing concept of immunological memory in innate host defence

    Mihai G Netea. Training innate immunity: the changing concept of immunological memory in innate host defence. European journal of clinical investigation , 43(8):881–884, 2013

  19. [27]

    Trained immunity: a memory for innate host de- fense

    Mihai G Netea, Jessica Quintin, and Jos WM van der Meer. Trained immunity: a memory for innate host de- fense. Cell host & microbe , 9(5):355–361, 2011

  20. [28]

    Viral cross-reactivity and antigenic determinants recognized by human parain- fluenza virus type 1-specific cytotoxic t-cells

    Vibhuti P Dave, Jane E Allan, Karen S Slobod, F Suzette Smith, Kevin W Ryan, Toru Takimoto, Ultan F Power, Allen Portner, and Julia L Hurwitz. Viral cross-reactivity and antigenic determinants recognized by human parain- fluenza virus type 1-specific cytotoxic t-cells. Virology,...

  21. [29]

    Club cells surviving influenza a virus infection induce tempo- rary nonspecific antiviral immunity

    Jennifer R Hamilton, David Sachs, Jean K Lim, Ryan A Langlois, Peter Palese, and Nicholas S Heaton. Club cells surviving influenza a virus infection induce tempo- rary nonspecific antiviral immunity. Proceedings of the National Academy of Sciences , 113(14):3861–3866, 2016

  22. [30]

    Myxoviruses: Parainfluenza 1

    RM Chanock, RH Parrott, KM Johnson, AZ Kapikian, and JA Am Bell. Myxoviruses: Parainfluenza 1. Amer- ican Review of Respiratory Disease , 88(3P2):152–166, 1963

  23. [31]

    Hemagglutinin sequence clusters and the antigenic evo- lution of influenza a virus

    Joshua B Plotkin, Jonathan Dushoff, and Simon A Levin. Hemagglutinin sequence clusters and the antigenic evo- lution of influenza a virus. Proceedings of the National Academy of Sciences , 99(9):6263–6268, 2002

  24. [32]

    In- fectious diseases of humans: dynamics and control , vol- ume 28, chapter 2

    Roy M Anderson, Robert M May, and B Anderson. In- fectious diseases of humans: dynamics and control , vol- ume 28, chapter 2. Wiley Online Library, 1992

  25. [33]

    Immunity to and frequency of reinfection with respiratory syncytial virus

    Caroline Breese Hall, Edward E Walsh, Christine E Long, and Kenneth C Schnabel. Immunity to and frequency of reinfection with respiratory syncytial virus. Journal of Infectious Diseases, 163(4):693–698, 1991

  26. [35]

    Lyapunov functions and global stability for sir, sirs, and sis epi- demiological models

    Andrei Korobeinikov and Graeme C Wake. Lyapunov functions and global stability for sir, sirs, and sis epi- demiological models. Applied Mathematics Letters , 15 (8):955–960, 2002

  27. [2011]

    doi:10.1098/rspb.2011.0300

    ISSN 0962-8452. doi:10.1098/rspb.2011.0300. URL http://rspb.royalsocietypublishing.org/content/ 278/1725/3635

Pith tools

Reviewed August 14, 2026 · model on record in the stance chip above.